Your browser doesn't support javascript.
loading
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations.
Seneschal, Julien; Speeckaert, Reinhart; Taïeb, Alain; Wolkerstorfer, Albert; Passeron, Thierry; Pandya, Amit G; Lim, Henry W; Ezzedine, Khaled; Zhou, Youwen; Xiang, Flora; Thng, Steven; Tanemura, Atsushi; Suzuki, Tamio; Rosmarin, David; Rodrigues, Michelle; Raboobee, Noufal; Pliszewski, Georg; Parsad, Davinder; Oiso, Naoki; Monteiro, Paul; Meurant, Jean Marie; Maquignon, Nicolle; Lui, Harvey; Le Poole, Caroline; Leone, Giovanni; Lee, Ai-Young; Lan, Eric; Katayama, Ichiro; Huggins, Richard; Oh, Sang Ho; Harris, John E; Hamzavi, Iltefat H; Gupta, Somesh; Grimes, Pearl; Goh, Boon Kee; Ghia, Deepti; Esmat, Samia; Eleftheriadou, Viktoria; Böhm, Markus; Benzekri, Laila; Bekkenk, Marcel; Bae, Jung Min; Alomar, Augustin; Abdallah, Marwa; Picardo, Mauro; van Geel, Nanja.
Afiliación
  • Seneschal J; Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, ImmunoConcept, CNRS UMR 5164, Bordeaux University, Bordeaux, France.
  • Speeckaert R; Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Taïeb A; Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, BRIC, UMR 1312, Inserm, University Bordeaux, Bordeaux, France.
  • Wolkerstorfer A; Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, The Netherlands.
  • Passeron T; Department of Dermatology, University Hospital of Nice, Nice, France.
  • Pandya AG; Department of Dermatology, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Lim HW; Department of Dermatology, Henry Ford Health, Detroit, Michigan, USA.
  • Ezzedine K; Department of Dermatology, University Hospital Henri Mondor, EpiDermE EA 7379, Université Paris-Est Créteil Val de Marne, Créteil, France.
  • Zhou Y; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
  • Xiang F; Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
  • Thng S; Skin Research Institute of Singapore, ASTAR, Singapore, Singapore.
  • Tanemura A; Department of Dermatology Integrated Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Suzuki T; Department of Dermatology, Yamagata University Faculty of Medicine, Yamagata, Japan.
  • Rosmarin D; Department of Dermatology, Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Rodrigues M; Chroma Dermatology, Pigment and Skin of Colour Centre, Wheelers Hill, Victoria, Australia.
  • Raboobee N; Department of Dermatology, The Royal Children's Hospital, Parkville, Victoria, Australia.
  • Pliszewski G; Department of Dermatology, Westville Hospital, Durban, South Africa.
  • Parsad D; Deutscher Vitiligo-Bund e.V., Adelsdorf, Germany.
  • Oiso N; Department of Dermatology, Venereology & Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Monteiro P; Department of Dermatology, Kindai University Nara Hospital, Ikoma, Japan.
  • Meurant JM; Vitiligo.nl, The Hague, The Netherlands.
  • Maquignon N; Vitiligo International Patient Organisations, Paris, France.
  • Lui H; Association Française du Vitiligo, Paris, France.
  • Le Poole C; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
  • Leone G; Department of Dermatology, Microbiology and Immunology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Lee AY; Photodermatology and Vitiligo Treatment Unit, Israelite Hospital, Roma.
  • Lan E; Department of Dermatology, College of Medicine, Dongguk University Ilsan Hospital, Goyang, Korea.
  • Katayama I; Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Huggins R; Pigmentation Research and Therapeutics, Osaka Metropolitan University, Osaka, Japan.
  • Oh SH; Department of Dermatology, Henry Ford Health, Detroit, Michigan, USA.
  • Harris JE; Department of Dermatology, Severance Hospital, Cutaneous Biology Research Institute, Yonsei University College of Medicine, Seoul, South Korea.
  • Hamzavi IH; Department of Dermatology, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Gupta S; Department of Dermatology, Henry Ford Health, Detroit, Michigan, USA.
  • Grimes P; Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India.
  • Goh BK; Vitiligo & Pigmentation Institute of Southern California, Los Angeles, California, USA.
  • Ghia D; Skin Physicians Pte Ltd, Singapore, Singapore.
  • Esmat S; Department of Dermatology, Jaslok Hospital and Research Hospital and South Mumbai Dermatology Clinic, Mumbai, India.
  • Eleftheriadou V; Department of Dermatology, Faculty of Medicine Cairo University, Cairo, Egypt.
  • Böhm M; New Cross Hospital, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.
  • Benzekri L; Department of Dermatology, University Hospital Münster, Münster, Germany.
  • Bekkenk M; Department of Dermatology, Mohammed V University, Ibn Sina University Hospital, Rabat, Morocco.
  • Bae JM; Department of Dermatology, Netherlands Institute for Pigment Disorders, Amsterdam University Medical Centers, Amsterdam Institute for Infection and Immunity, VU University, Amsterdam, The Netherlands.
  • Alomar A; Department of Dermatology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Abdallah M; Department of Dermatology, Clinica Dermatologica Moragas, Barcelona, Spain.
  • Picardo M; Dermatology, Andrology, and Venereology Department, Ain Shams University, Cairo, Egypt.
  • van Geel N; Unicamillus International University, Rome, Italy.
J Eur Acad Dermatol Venereol ; 37(11): 2185-2195, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37715487
BACKGROUND: The treatment of vitiligo can be challenging. Up-to-date agreed consensus recommendations on the use of topical and systemic therapies to facilitate the clinical management of vitiligo are currently lacking. OBJECTIVES: To develop internationally agreed-upon expert-based recommendations for the treatment of vitiligo. METHODS: In this consensus statement, a consortium of 42 international vitiligo experts and four patient representatives participated in different online and live meetings to develop a consensus management strategy for vitiligo. At least two vitiligo experts summarized the evidence for different topics included in the algorithms. A survey was then given to a core group of eight experts to resolve the remaining issues. Subsequently, the recommendations were finalized and validated based on further input from the entire group during two live meetings. RESULTS: The recommendations provided summarize the latest evidence regarding the use of topical therapies (steroids, calcineurin inhibitors and Jak-inhibitors) and systemic therapies, including steroids and other systemic immunomodulating or antioxidant agents. The different modalities of phototherapies (NB-UVB, photochemotherapy, excimer devices and home phototherapy), which are often combined with other therapies, are also summarized. Interventional approaches as well as depigmentation strategies are presented for specific indications. Finally, the status of innovative and targeted therapies under development is discussed. CONCLUSIONS: This international consensus statement culminated in expert-based clinical practice recommendations for the treatment of vitiligo. The development of new therapies is ongoing in vitiligo, and this will likely improve the future management of vitiligo, a disease that still has many unmet needs.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fotoquimioterapia / Terapia Ultravioleta / Vitíligo Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fotoquimioterapia / Terapia Ultravioleta / Vitíligo Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido